Navigation Links
Watson Reaches Settlement with Mallinckrodt Over Exalgo(R)
Date:1/26/2012

PARSIPPANY, N.J., Jan. 26, 2012 /PRNewswire/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI) today announced that its subsidiary, Watson Laboratories, Inc.- Florida has reached a settlement with Mallinckrodt Inc. on outstanding patent litigation related to Watson's generic versions of Mallinckrodt's Exalgo® (Hydromorphone Hydrochloride Extended-Release ) tablets.  Mallinckrodt filed its lawsuit on December 10, 2010 in the United States District Court for the District of New Jersey following Watson's filing of an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market its product in the 8 mg, 12 mg, and 16 mg dosage strengths.
Under terms of the settlement agreement, Mallinckrodt has granted Watson a royalty-free license to U.S. patents relating to Exalgo®.  Watson will have the right to launch its bioequivalent products on November 15, 2013.  Other details of the settlement were not disclosed.

Based on available information, Watson believes it may be a "first applicant" to file an ANDA for the generic version of Exalgo® and, should its ANDA be approved, may be entitled to 180 days of generic market exclusivity.

About Watson Pharmaceuticals, Inc.Watson Pharmaceuticals, Inc. is an integrated global specialty pharmaceutical company. The Company is engaged in the development, manufacturing, marketing and distribution of generic pharmaceuticals and specialized branded pharmaceutical products focused on Urology and Women's Health. Watson has operations in many of the world's established and growing international markets.

For press release and other company information, visit Watson Pharmaceuticals' Web site at http://www.watson.com.

Forward-Looking Statement Statements contained in this press release that refer to non-h
'/>"/>

SOURCE Watson Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Watson Launches Generic Biaxin(R) XL
2. Watson Announces Positive Results From Its Pivotal Study of Oxybutynin Topical Gel for the Treatment of Overactive Bladder
3. Watson Announces Silodosin NDA Accepted for Filing by FDA for the Treatment of Benign Prostatic Hyperplasia
4. Watson Announces Positive Data for Its New Investigational Products for Benign Prostatic Hyperplasia and Overactive Bladder
5. Watson Announces United States Availability of RAPAFLO(TM) (silodosin), a Novel New Treatment in Benign Prostatic Hyperplasia (BPH)
6. Watson and Barr Settle Lawsuit Over Oxytrol(R)
7. Watson to Host Conference Call and Webcast to Discuss Fourth Quarter 2009 Earnings and 2010 Outlook
8. Watson Completes Acquisition of Eden Biodesign
9. Watson to Present at Credit Suisse Healthcare Conference
10. Watson Announces New Program to Help Promote Good Bone Health in Advanced Prostate Cancer Patients on Long-Term Androgen Deprivation Therapy
11. Watson Files FDA Application for Generic Rozerem(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2015)... , Feb. 26, 2015  Tandem Diabetes Care®, ... company and manufacturer of the t:slim® and t:flex™ Insulin ... offering of 5,250,000 shares of its common stock at ... The net proceeds to Tandem from this offering are ... and commissions and other estimated offering expenses payable by ...
(Date:2/26/2015)... 2015  Today the National Safety Council ... physical side effects of pain medications , ... Vicodin and Oxycontin, are safer options than over-the-counter pain ... painkillers than on heroin and cocaine combined," said ... "Yet, these medications are marketed as the Cadillac option ...
(Date:2/26/2015)... SOUTH BEND, Ind. , Feb. 26, 2015 /PRNewswire/ ... to announce an agreement with Bank of America (NYSE: ... for consumers nationwide to receive financing of the revolutionary ... accessible vehicle, designed from the ground up to provide ... users. Approved applicants can use their loan to purchase ...
Breaking Medicine Technology:Tandem Diabetes Care Announces Pricing of Underwritten Public Offering of Common Stock 2Tandem Diabetes Care Announces Pricing of Underwritten Public Offering of Common Stock 3National Safety Council: Opioid prescription painkillers have hidden, deadly side effects 2Mobility Ventures and Bank of America Announce New Agreement to Simplify Retail Consumer Financing for MV-1 Universally Accessible Vehicle 2Mobility Ventures and Bank of America Announce New Agreement to Simplify Retail Consumer Financing for MV-1 Universally Accessible Vehicle 3
... Grove, MN, announced today that the results of the ... of its NeuroFlo™ catheter – were presented on Saturday, ... at the 2010 World Stroke Congress in Seoul, South ... randomized trial of an acute interventional treatment in ischemic ...
... WASHINGTON, Pa., Oct. 18 McNeil Consumer Healthcare, Division ... TYLENOL® 8 Hour caplets 50 count bottles to the ... small number of complaints of a musty or moldy ... by the presence of trace amounts of a chemical ...
Cached Medicine Technology:CoAxia Announces Results of SENTIS Ischemic Stroke Trial 2CoAxia Announces Results of SENTIS Ischemic Stroke Trial 3McNeil Consumer Healthcare Announces Voluntary Recall of One Product Lot of TYLENOL® 8 Hour Caplets 50 Count Sold in the United States and Puerto Rico 2
(Date:2/28/2015)... February 28, 2015 “ Powermod ” was ... which takes a look at the latest and coolest technology ... reporter for NewsWatch and a technology expert, conducted the review ... of charging solutions. , Getting stuck with a low battery ... a problem that people face on a daily basis. Even ...
(Date:2/28/2015)... 28, 2015 My Shiney Hiney® LLC., the ... team to Las Vegas, Nevada for the annual ASD Market ... of the leading consumer-goods tradeshows and My Shiney Hiney will ... event. My Shiney Hiney can be found at booth number ... for the at-home personal hygiene brush and cleansing system exclusively ...
(Date:2/27/2015)... CA (PRWEB) February 27, 2015 ... Devices (IPD), has introduced miniature, wire bondable, silicon ESD ... Power LED markets. The ESD88NP and ... currents away from sensitive LED and IC products. ... Multilayer Varistors (MLV). All devices meet the requirements ...
(Date:2/27/2015)... February 27, 2015 Today, February 27th, is ... Brothers , along with LXR Organics and ... IT Campaign to raise awareness and promote prevention, rescue and ... provided by the END IT Coalition, slavery is the 2nd ... and exists in 167 countries around the world. Slavery includes ...
(Date:2/27/2015)... (PRWEB) February 27, 2015 Altec Products, ... as their Sage ERP Document Management Partner of the ... ERP, Sage CRM and other complimentary solutions for their ... worked side-by-side for many years to provide clients with ... applications. , “We are thrilled to recognize ADSS ...
Breaking Medicine News(10 mins):Health News:Solutions to Keep Phones Charged were Featured on NewsWatch Television on January 29, 2015 2Health News:My Shiney Hiney® to Participate in ASD Market Week 2015 2Health News:OnChip Introduces New Series of Space Saving Bare-die Zener Diodes for Transient Voltage Suppression 2Health News:OnChip Introduces New Series of Space Saving Bare-die Zener Diodes for Transient Voltage Suppression 3Health News:KAJ Brothers Join the Campaign to 'End It - Shine A Light On Slavery' 2Health News:Altec Announces 2014 Sage ERP Document Management Partner of the Year Award Recipient 2
... ... by the 1998 Nobel Prize winner in Medicine is a boon for anyone who wants ... ... Dr. Mercola of Mercola.com released yesterday a new heart health product that also ...
... activity per week, experts say , FRIDAY, April 2 ... States do not get the recommended amount of exercise, ... 150 minutes of moderate-intensity aerobic activity per week, according ... Moderate-intensity exercise causes light sweating or a slight to ...
... Children,s Hospital Boston,s Pain Treatment Service has been named a ... honor that is bestowed upon five pain centers each year. ... nomination process. "We are honored to be named a ... Charles Berde, MD, PhD, chief of the pain management department ...
... Most deaths occurred when babies slept somewhere other than a ... are 12 times more likely to die from sleep-related causes ... shows. , Overall in the state of Illinois, where the ... to die from sleep-related causes. , Researchers in the Child ...
... ... vaccination rates, , ... Washington, DC (Vocus) April 2, 2010 -- The American Pharmacists Association (APhA) applauds the ... efforts to administer more than 90 million doses during the 2009-2010 influenza season. ...
... vice president of Emergency Medicine Clinical Operations at Thomas ... Department Director of the Year by the Emergency Medicine ... receive his award at the American College of Emergency ... "I am extremely honored to be recognized in such ...
Cached Medicine News:Health News:New Heart Health Booster Supports Blood Pressure in the Normal Range* 2Health News:New Heart Health Booster Supports Blood Pressure in the Normal Range* 3Health News:Only 1 in 4 Pregnant Women Gets Enough Exercise 2Health News:Sleep-Related Death Rate Higher Among Black Infants 2Health News:Pharmacists Play a Vital Role in Providing Immunizations in Their Communities, 2Health News:Pharmacists Play a Vital Role in Providing Immunizations in Their Communities, 3Health News:Jefferson physician named 2010 Emergency Department Director of the Year 2
Features soft, low friction sheath that extends beyond the tip....
Designed to retain the desired curve during oral intubation....
Facilitates intubation of tracheal tubes....
Facilitates intubation of tracheal tubes....
Medicine Products: